|

Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

RECRUITINGN/ASponsored by Wonju Severance Christian Hospital
Actively Recruiting
PhaseN/A
SponsorWonju Severance Christian Hospital
Started2024-02-22
Est. completion2026-12-31
Eligibility
Age19 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06250712

Summary

The HELP-A study is a multicenter, randomized, controlled trial. A total of 588 patients were enrolled during the 4-year enrollment period and followed for 1 month. This study aims to compare the diagnostic yield of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms.

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
* Patients who can use a smartphone

Exclusion Criteria:

* Patients who have cardiac implantable electronic devices(CIEDs)
* Patients who can't use handheld ECG
* Patient who had syncope

Conditions2

ArrhythmiaHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.